Tumor Size Improves the Accuracy of TNM Predictions in Patients with Renal Cancer

European Urology

Volumn 50, Issue 3, 2006, Pages 521-529

  Karakiewicz, Pierre I ^a   Lewinshtein, Daniel J ^a   Chun, Felix K H ^a   Briganti, Alberto ^a   Guille, Francois ^b   Perrotte, Paul ^a   Lobel, Bernard ^b   Ficarra, Vincenzo ^c   Artibani, Walter ^c   Cindolo, Luca ^d   Tostain, Jacques ^e   Abbou, Clement Claude ^f   Chopin, Dominique ^f   De La Taille, Alexandre ^f   Patard, Jean Jacques ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITY OF VERONA   (Italy)

^d G RUMMO HOSPITAL   (Italy)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^f HENRI MONDOR HOSPITAL   (France)

Author keywords

Cancer specific survival; Distant metastases; Nodal metastases; Predictive accuracy; Renal cancer; Tumor size

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLEAR CELL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

CARCINOMA, RENAL CELL; COHORT STUDIES; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM STAGING; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 33746866414     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.02.034     Document Type: Article

References (28)

1. Hofmann H.S., Neef H., Krohe K., Andreev P., and Silber R.E. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48 (2005) 77-81
2. Kuczyk M., Wegener G., and Jonas U. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. Eur Urol 48 (2005) 252-257
3. Terrone C., Cracco C., Guercio S., et al. Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma. Eur Urol 46 (2004) 472-476
4. Guinan P., Sobin L.H., Algaba F., et al. TNM staging of renal cell carcinoma: Workgroup no. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 992-993
5. Zisman A., Pantuck A.J., Wieder J., et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20 (2002) 4559-4566
6. Kattan M.W., Reuter V., Motzer R.J., Katz J., and Russo P. A postoperative nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
7. Sorbellini M., Kattan M.W., Snyder M.E., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173 (2005) 48-51
8. Frank I., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
9. Schips L., Lipsky K., Zigeuner R., et al. Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology 62 (2003) 1024-1028
10. Ficarra V., Prayer-Galetti T., Novara G., et al. Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma. Urology 63 (2004) 235-240
11. Ficarra V., Novara G., Galfano A., and Artibani W. Neoplasm staging and organ-confined renal cell carcinoma: a systematic review. Eur Urol 46 (2004) 559-564
12. Ficarra V., Guille F., Schips L., et al. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 104 (2005) 2116-2123
13. Steiner T., Knels R., and Schubert J. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46 (2004) 327-330
14. Cagiannos I., Karakiewicz P., Eastham J.A., et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170 (2003) 1798-1803
15. Karakiewicz P.I., Lattouf J.B., Perrotte P., et al. Validation of 1997 Partin tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal, Quebec. Can J Urol 12 (2005) 2588-2592
16. Gospodarowicz M.K., Miller D., Groome P.A., Greene F.L., Logan P.A., and Sobin L.H. The process for continuous improvement of the TNM classification. Cancer 100 (2004) 1-5
17. Patard J.J., Leray E., Rioux-Leclercq N., et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23 (2005) 2763-2771
18. Storkel S., Eble J.N., Adlakha K., et al. Classification of renal cell carcinoma: Workgroup no. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 987-989
19. Patard J.J., Leray E., Rodriguez A., Rioux-Leclercq N., Guille F., and Lobel B. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 44 (2003) 226-232
20. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
21. Kattan M.W., Shariat S.F., Andrews B., et al. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. J Clin Oncol 21 (2003) 3573-3579
22. Kattan M.W., Leung D.H., and Brennan M.F. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 20 (2002) 791-796
23. International Germ Cell Cancer Collaborative Group:. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15 (1997) 594-603
24. Patard J.J., Dorey F.J., Cindolo L., et al. Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol 172 (2004) 2167-2171
25. Begg C.B., Cramer L.D., Venkatraman E.S., and Rosai J. Comparing tumor staging and grading systems: a case study and a review of the issues, using thymoma as a model. Stat Med 19 (2000) 1997-2014
26. Kattan M.W., Reuter V., Motzer R.J., Katz J., and Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
27. Kattan M.W., Zelefsky M.J., Kupelian P.A., Scardino P.T., Fuks Z., and Leibel S.A. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 18 (2000) 3352-3359
28. Kattan M.W. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol 13 (2003) 111-116